FDAnews Device Daily Bulletin
Medical Devices / Submissions and Approvals

FDA Clears Expanded Indication for Vidas Brahms PCT Assay for Lower Respiratory Tract Infections

Feb. 27, 2017

The FDA has cleared the expanded use of the Vidas Brahms PCT Assay to help health care providers determine if antibiotic treatment should be started or stopped in patients with lower respiratory tract infections, such as community-acquired pneumonia, and stopped in patients with sepsis.

The test is intended to be used in the hospital or emergency room. — Cynthia Jessup

View today's stories